Revance(RVNC) - 2023 Q4 - Earnings Call Transcript

Revance Therapeutics Inc. (NASDAQ:RVNC) Q4 2023 Earnings Call Transcript February 28, 2024 4:30 PM ET Company Participants Jessica Serra - Head of Investor Relations & ESG Mark Foley - CEO & Director Tobin Schilke - CFO & Principal Accounting Officer Conference Call Participants David Amsellem - Piper Sandler Stacy Ku - TD Cowen Karishma Raghuram - Goldman Sachs Jack Padovano - Stifel Alana Lelo - Guggenheim John Boyle - William Blair Terence Flynn - Morgan Stanley Navann Ty - BNP Paribas Serge Belanger - N ...